UBS Group AG - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,198
-26.3%
6,206
+1.0%
0.00%
Q2 2023$21,988
-89.8%
6,142
-93.8%
0.00%
Q1 2023$216,112
+67.7%
99,134
+825.4%
0.00%
Q4 2022$128,865
+138.6%
10,712
+27.3%
0.00%
Q3 2022$54,000
+157.1%
8,415
+84.9%
0.00%
Q2 2022$21,000
-19.2%
4,551
+50.1%
0.00%
Q1 2022$26,000
-86.7%
3,031
-77.8%
0.00%
Q4 2021$195,000
+650.0%
13,676
+1064.9%
0.00%
Q3 2021$26,000
-92.7%
1,174
-95.6%
0.00%
Q2 2021$357,000
+1883.3%
26,681
+1396.4%
0.00%
Q1 2021$18,000
+1700.0%
1,783
+1250.8%
0.00%
Q4 2020$1,000
-95.8%
132
-98.6%
0.00%
Q3 2020$24,000
+60.0%
9,359
+132.2%
0.00%
Q2 2020$15,000
-37.5%
4,030
-47.1%
0.00%
Q1 2020$24,000
+2300.0%
7,623
+3711.5%
0.00%
Q4 2019$1,000
-83.3%
200
-88.5%
0.00%
Q3 2019$6,000
-14.3%
1,734
-9.8%
0.00%
Q2 2019$7,000
+40.0%
1,923
+56.3%
0.00%
Q1 2019$5,000
-44.4%
1,230
-56.0%
0.00%
Q4 2018$9,000
-43.8%
2,797
-12.4%
0.00%
Q3 2018$16,000
-73.8%
3,193
-60.9%
0.00%
Q2 2018$61,000
+7.0%
8,166
-7.4%
0.00%
Q1 2018$57,000
-63.7%
8,816
-49.4%
0.00%
Q4 2017$157,000
+528.0%
17,429
+601.7%
0.00%
Q3 2017$25,000
+1150.0%
2,484
+728.0%
0.00%
Q2 2017$2,000
-33.3%
300
-21.7%
0.00%
Q1 2017$3,000
-62.5%
383
-71.8%
0.00%
Q4 2016$8,000
-42.9%
1,359
-28.7%
0.00%
Q3 2016$14,000
+180.0%
1,906
+208.9%
0.00%
Q2 2016$5,000
-37.5%
617
-51.9%
0.00%
Q1 2016$8,000
+60.0%
1,284
+108.1%
0.00%
Q4 2015$5,000
+66.7%
6170.0%0.00%
Q3 2015$3,000
-85.0%
617
-81.9%
0.00%
Q2 2015$20,000
+17.6%
3,401
+26.4%
0.00%
Q1 2015$17,000
+142.9%
2,691
+77.4%
0.00%
Q4 2014$7,0001,5170.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders